Cargando…
Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma
Due to our inability to exactly characterize tumours, many patients with urinary bladder cancer undergo unnecessary surgery or cytostatic therapy. We have here studied the expression of the cytokine interleukin-1α (IL-1α) in 73 human bladder carcinomas in relation to patient survival, and examined p...
Autores principales: | Seddighzadeh, M, Steineck, G, Jansson, O, Larsson, P, Wijkström, H, Adolfsson, J, Portwood, N, Hansson, J, Linder, S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363735/ https://www.ncbi.nlm.nih.gov/pubmed/11161396 http://dx.doi.org/10.1054/bjoc.2000.1584 |
Ejemplares similares
-
p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001) -
Interleukin-2 gene transfer into human transitional cell carcinoma of the urinary bladder
por: Milella, M, et al.
Publicado: (1999) -
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder
por: Kimura, F, et al.
Publicado: (2001) -
Automatic quantification of microvessel density in urinary bladder carcinoma
por: Wester, K, et al.
Publicado: (1999) -
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer
por: Protheroe, A S, et al.
Publicado: (1999)